DreaMS - Validation Study 1
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05009160 |
|
Recruitment Status :
Recruiting
First Posted : August 17, 2021
Last Update Posted : June 13, 2022
|
Sponsor:
Research Center for Clinical Neuroimmunology and Neuroscience Basel
Collaborators:
Healios AG
University Hospital, Basel, Switzerland
University of Basel
Innosuisse - Swiss Innovation Agency
Novartis Pharmaceuticals
Hoffmann-La Roche
Information provided by (Responsible Party):
Research Center for Clinical Neuroimmunology and Neuroscience Basel
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | April 2025 |
| Estimated Study Completion Date : | April 2025 |